Stepan Company (SCL)

NYSE Materials Specialty Chemicals S&P SmallCap 600
$66.94
-0.91 (-1.34%)
Close of Nov 06, 2026 · end-of-day data
Next earnings date
Not scheduled yet
No report date announced in the next three weeks.
Consensus EPS estimate
—
Shown once a date is announced.
Trailing 12-month EPS
$0.19
Diluted, last four reported quarters

Earnings surprise history

reported EPS vs consensus
ReportedQuarterEPS estimateReported EPSSurprise
Oct 28, 2026Sep/2026$0.73$0.94+28.8%

Our record of SCL's reports since we began tracking; it grows each quarter.

Latest results, in brief

All SCL 8-K briefs →
Oct 28, 7:00 AM ET

Stepan Q3 Net Income Rises 64% to $17.8 Million; Quarterly Dividend Raised to $0.405

Mixed earnings 2.028.01

Stepan reported third quarter 2026 net sales of $692.2 million, up 17%, and net income of $17.8 million, up 64%, with diluted EPS of $0.78 versus $0.47. Nine-month results were a net loss of $0.7 million because of a $76.1 million pre-tax restructuring charge tied to Project Catalyst, and the company said it expects full-year Adjusted EBITDA growth and positive free cash flow in 2026. The board also declared a $0.405 quarterly dividend, a $0.010 increase.

  • Q3 2026 net sales $692.2 million, up 17% year-over-year; Q3 Adjusted EBITDA $66.3 million, up 18%
  • Nine months 2026 net loss of $0.7 million versus $41.9 million of income in 2025, driven by a $76.1 million pre-tax restructuring charge
  • Quarterly dividend of $0.405 per share, payable December 15, 2026, to holders of record on December 1, 2026; 59th consecutive annual increase
  • Company expects full-year 2026 Adjusted EBITDA growth, positive free cash flow and continued balance sheet de-leveraging
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Quarter endedRevenueYoYEPS (diluted)YoYNet incomeNet margin
Sep 2026$692.15M+17.3% $0.78+66.0% $17.81M2.6%
Jun 2026$684.11M+15.0% $1.00+100.0% $22.91M3.3%
Mar 2026$604.51M+1.9% $-1.81-310.5% -$41.41M-6.8%
Dec 2025$553.89M+5.4% $0.22+46.7% $5.00M0.9%
Sep 2025$590.28M+7.9% $0.47-54.4% $10.84M1.8%
Jun 2025$594.69M+6.9% $0.50+19.0% $11.34M1.9%
Mar 2025$593.25M+7.6% $0.86+41.0% $19.71M3.3%
Dec 2024$525.61M-1.2% $0.15— $3.35M0.6%

From Stepan Company's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.

Annual results

Fiscal yearRevenueGrowthEPS (diluted)GrowthNet margin
FY2025$2.33B+7.0% $2.05-6.8%2.0%
FY2024$2.18B-6.3% $2.20+25.7%2.3%
FY2023$2.33B-16.1% $1.75-72.6%1.7%
FY2022$2.77B+18.2% $6.38+7.8%5.3%
FY2021$2.35B+25.5% $5.92+8.6%5.9%

Frequently asked questions

When is Stepan's next earnings date?

Stepan has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.

What did Stepan earn last quarter?

For the quarter ended Sep 2026, Stepan reported diluted EPS of $0.78 (+66.0% year over year) on revenue of $692.15M (+17.3%).

Where do these numbers come from?

Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.

Not investment advice. Figures can be restated by the company in later filings.